Skip to content

The efficacy of eucalyptus essence inhalation in hospitalized patients with COVID-19

Evaluation of the efficacy of eucalyptus essence inhalation in hospitalized patients with COVID-19: a clinical trial study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201127049507N1
Enrollment
40
Registered
2021-08-22
Start date
2021-09-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID -19 disease.

Interventions

Intervention 1: Intervention group: The intervention group will receive routine ward care as well as 2cc essence of Eucalyptus, that will be prepared in the Jihad Agricultural Unit of University of Te

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: People with a diagnosis of COVID -19 and hospitalization in general wards Having the necessary ability to conduct studies Involvement of lung tissue according to CT scan In both sexes men and women in the age group of 18 to 70 years who have recently been admitted Have signed the informed consent form to participate in the study They do not participate in another clinical trial at the same time

Exclusion criteria

Exclusion criteria: History of previous illness Pregnancy and lactation Serious heart and lung disease Blood pressure above 160 mm Hg history of allergic symptoms Consumption of herbal perfumes as well as synthetic sprays effective on airway obstruction

Design outcomes

Primary

MeasureTime frame
Arterial oxygen saturation. Timepoint: Every 24 hours. Method of measurement: With pulse oximetry device.;Respiratory rate. Timepoint: every 24 hours. Method of measurement: By monitoring device.;Blood pressure. Timepoint: every 24 hours. Method of measurement: By monitoring device.;Heart rate. Timepoint: every 24 hours. Method of measurement: By monitoring device.;White blood cells. Timepoint: every 24 hours. Method of measurement: Perform a complete blood count test.;Fever. Timepoint: every 24 hours. Method of measurement: By thermometer device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIman Khahan Yazdi

Ghoum University of Medical Sciences

imankhahan@yaho.com+98 25 3107 1111

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026